Use of Varenicline vs. Bupropion and Risk of Psychiatric Adverse Events

被引：0
|
作者：
Pasternak, Bjorn [1 ]
Svanstrom, Henrik [1 ]
Hviid, Anders [1 ]
机构：
[1] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
774
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [21] Risk of Psychiatric Adverse Events Among Montelukast Users
    Sansing-Foster, Veronica
    Haug, Nicole
    Mosholder, Andrew
    Cocoros, Noelle M.
    Bradley, Marie
    Ma, Yong
    Pennap, Dinci
    Dee, Elizabeth C.
    Toh, Sengwee
    Pestine, Ella
    Petrone, Andrew B.
    Kim, Ivone
    Lyons, Jennifer G.
    Eworuke, Efe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (01): : 385 - 393.e12
  • [22] Risk for adverse outcome events according to paroxysmal vs. non-paroxysmal atrial fibrillation
    Blum, S.
    Aeschbacher, S.
    Meyre, P.
    Ammann, P.
    Erne, P.
    Moschovitis, G.
    Di Valentino, M.
    Shah, D.
    Schlaepfer, J.
    Kuehne, M.
    Sticherling, C.
    Osswald, S.
    Conen, D.
    EUROPEAN HEART JOURNAL, 2017, 38 : 979 - 979
  • [23] Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
    Prochaska, Judith J.
    Hilton, Joan F.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [24] Predicting adverse cardiovascular events in bupropion overdose
    Simpson, Michael
    Campleman, Sharan
    Brent, Jeffrey
    Wax, Paul
    Manini, Alex
    CLINICAL TOXICOLOGY, 2023, 61 : 106 - 106
  • [25] Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
    Thomas, Kyla H.
    Martin, Richard M.
    Knipe, Duleeka W.
    Higgins, Julian P. T.
    Gunnell, David
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [26] Review: Nicotine replacement therapy increases CVD events; bupropion and varenicline do not
    Rowland, Kate
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (08)
  • [27] Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors
    Beard, Emma
    Jackson, Sarah E.
    Anthenelli, Robert M.
    Benowitz, Neal L.
    Aubin, Lisa St.
    McRae, Thomas
    Lawrence, David
    Russ, Cristina
    Krishen, Alok
    Evins, A. Eden
    West, Robert
    ADDICTION, 2021, 116 (10) : 2816 - 2824
  • [28] Systemic steroids vs. local acting steroids: Relative risk for corticosteroid-related adverse events
    Timeus, S.
    Hofmann, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S309 - S309
  • [29] Adverse Neuropsychiatric Events Associated with Varenicline: A Case Series
    Menku, Burak Erman
    Altiparmak, Taylan
    Genis, Bahadir
    Cosar, Behcet
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2021, 11 (01): : 80 - 83
  • [30] The Risk Of Cardiovascular And Neuropsychiatric Adverse Events Following Varenicline Use For Tobacco Cessation In Ontario, Canada: A Self-Controlled Study
    Gershon, A. S.
    Campitelli, M. A.
    Hawken, S.
    Victor, J. C.
    Sproule, B.
    Kurdyak, P.
    Selby, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345